Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C25H42O5 |
| Molecular Weight | 422.598 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 11 / 11 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C
InChI
InChIKey=DLYVTEULDNMQAR-SRNOMOOLSA-N
InChI=1S/C25H42O5/c1-14(5-8-22(29)30-4)17-6-7-18-23-19(13-21(28)25(17,18)3)24(2)10-9-16(26)11-15(24)12-20(23)27/h14-21,23,26-28H,5-13H2,1-4H3/t14-,15+,16-,17-,18+,19+,20-,21+,23+,24+,25-/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/15283464
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15283464
Methyl cholate is a cholesterol biosynthesis inhibitor. It exhibited inhibitory effect on the later step of cholesterol biosynthesis, indicating that its action mode is different from that of statins that act on the HMG-CoA reductase.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2047 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18603830 |
|||
Target ID: WP197 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15283464 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Biotransformation of methyl cholate by Aspergillus niger. | 2008-09-05 |
|
| The novel compounds that activate farnesoid X receptor: the diversity of their effects on gene expression. | 2008-07 |
|
| OATP8/1B3-mediated cotransport of bile acids and glutathione: an export pathway for organic anions from hepatocytes? | 2006-10-13 |
|
| Selective acylation of cholic acid derivatives with multiple methacrylate groups. | 2005-07 |
|
| A cholesterol biosynthesis inhibitor from Rhizopus oryzae. | 2004-06 |
|
| Mixed steroidal 1,2,4,5-tetraoxanes: antimalarial and antimycobacterial activity. | 2002-08-01 |
Sample Use Guides
At least 15 patients reported by Gonzales et al. (2009), have been treated, most of them for more than 10 years, with cholic acid preparations that have contained between 0.4 to 0.5% of methyl cholate.
Route of Administration:
Unknown
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
10960835
Created by
admin on Mon Mar 31 22:09:18 GMT 2025 , Edited by admin on Mon Mar 31 22:09:18 GMT 2025
|
PRIMARY | |||
|
1448-36-8
Created by
admin on Mon Mar 31 22:09:18 GMT 2025 , Edited by admin on Mon Mar 31 22:09:18 GMT 2025
|
PRIMARY | |||
|
215-903-7
Created by
admin on Mon Mar 31 22:09:18 GMT 2025 , Edited by admin on Mon Mar 31 22:09:18 GMT 2025
|
PRIMARY | |||
|
E1P59HQX4Q
Created by
admin on Mon Mar 31 22:09:18 GMT 2025 , Edited by admin on Mon Mar 31 22:09:18 GMT 2025
|
PRIMARY | |||
|
DTXSID40932412
Created by
admin on Mon Mar 31 22:09:18 GMT 2025 , Edited by admin on Mon Mar 31 22:09:18 GMT 2025
|
PRIMARY | |||
|
126794
Created by
admin on Mon Mar 31 22:09:18 GMT 2025 , Edited by admin on Mon Mar 31 22:09:18 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD